SLN12140

DRUG3 trials

Sponsors

Linno Pharmaceuticals, Inc.

Conditions

Healthy VolunteerIgA Nephropathy (IgAN)Paroxysmal Nocturnal Hemoglobinuria (PNH)

Phase 1

Study of SLN12140 in Healthy Adult Participants

Not yet recruitingNCT06945445

Linno Pharmaceuticals, Inc.Healthy Volunteer

Start: 2025-04-30End: 2026-06-30Target: 56Updated: 2025-04-25

Phase 2

SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China

Not yet recruitingNCT07387302

Linno Pharmaceuticals, Inc.Paroxysmal Nocturnal Hemoglobinuria (PNH)

Start: 2026-02-10End: 2027-12-31Target: 10Updated: 2026-02-04

SLN12140 in Adult Participants With IgA Nephropathy in China

Not yet recruitingNCT07553494

Linno Pharmaceuticals, Inc.IgA Nephropathy (IgAN)

Start: 2026-05-29End: 2028-12-01Target: 48Updated: 2026-04-28